Multiple myeloma
Multiple myeloma
Biochemistry Block I
Biochemistry Block I
Definitions of acids and bases
Physiologic pH and buffers
Acid-base map and compensatory mechanisms
Strong acid-strong base titration
Acid-base disturbances: Pathology review
Metabolic acidosis
Metabolic and respiratory acidosis: Clinical
Amino acids and protein folding
Alport syndrome
Ehlers-Danlos syndrome
Oxygen-hemoglobin dissociation curve
Sickle cell disease (NORD)
Carbon dioxide transport in blood
Cell membrane
Selective permeability of the cell membrane
Enzyme function
Cell signaling pathways
Kwashiorkor
Osteogenesis imperfecta
ELISA (Enzyme-linked immunosorbent assay)
Anticoagulants: Warfarin
Protease inhibitors
Vitamin C deficiency
Anticoagulants: Heparin
Heparin-induced thrombocytopenia
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Multiple myeloma
Blood groups and transfusions
Hemophilia
Coagulation (secondary hemostasis)
Platelet plug formation (primary hemostasis)
Methemoglobinemia
Alpha-thalassemia
Beta-thalassemia
Pulmonary changes at high altitude and altitude sickness
Factor V Leiden
Clot retraction and fibrinolysis
Anticoagulants: Direct factor inhibitors
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Antithrombin III deficiency
Epidermolysis bullosa
Epidermolysis bullosa: Year of the Zebra
Key Takeaways
Multiple myeloma is a type of cancer that affects the plasma cells in the bone marrow. It is characterized by an overgrowth of abnormal plasma cells, which can cause damage to the bones, weaken the immune system, and produce an excess of certain proteins in the blood. Symptoms of multiple myeloma may include bone pain, fatigue, anemia, kidney problems, and frequent infections.